OXON HILL, Md. – Depending on how one measures the Medical Device Single Audit Program, it is either coming along nicely or is in danger of dying on the vine, but Kim Trautman, the former FDA liaison for the MDSAP program, told attendees at a conference held just outside the American capital that these inspections will include a much closer examination of purchasing controls in the future. Read More
